Nova Eye Medical Limited (ASX:EYE)

Australia flag Australia · Delayed Price · Currency is AUD
0.130
-0.015 (-10.34%)
Apr 29, 2026, 3:53 PM AEST
31.31%
Market Cap 41.30M
Revenue (ttm) 33.05M
Net Income (ttm) -7.03M
Shares Out 284.84M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 668,994
Average Volume 201,891
Open 0.145
Previous Close 0.145
Day's Range 0.127 - 0.145
52-Week Range 0.100 - 0.205
Beta 0.92
RSI 49.65
Earnings Date May 26, 2026

About Nova Eye Medical

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1970
Employees 301
Stock Exchange Australian Securities Exchange
Ticker Symbol EYE
Full Company Profile

Financial Performance

In fiscal year 2025, Nova Eye Medical's revenue was 29.27 million, an increase of 25.47% compared to the previous year's 23.33 million. Losses were -9.06 million, 3.06% more than in 2024.

Financial Statements

News

There is no news available yet.